Skip to main content
. Author manuscript; available in PMC: 2019 Mar 20.
Published in final edited form as: Gene. 2018 Jan 9;647:136–142. doi: 10.1016/j.gene.2018.01.013

Table 1.

Characteristics of studied population including the distribution of FTO rs9939609 polymorphism genotypes stratified by recurrent and non-recurrent status

Parameters Non
recurrent
VTE n (%)
Recurrent VTE
n (%)
Total
n (%)
P-
value
FTO genotype rs9939609
TT 375 (32.5) 44 (29.9) 419 (32.2)
AT 575 (49.9) 70 (47.6) 645 (49.6) 0.352
AA 203 (17.6) 33 (22.4) 236 (18.2)
TT and AT 950 (82.4) 114 (77.6) 1064 (81.8) 0.172
AA 203 (17.6) 33 (22.4) 236 (18.2)
Age a inclusion
Years, Median (IQR) 66.4 (24) 63.4 (24) 65.8 (24) 0.088
BMI
Mean±SD 26.6±4.7 27.4±5.1 26.6±4.8 0.066*
Sex
Male 565 (48.6) 78 (52.7) 643 (49.0) 0.383
Female 598 (51.4) 70 (47.3) 668 (51.0)
DVT+PE
DVT 736(68.2) 98 (68.5) 834 (68.2) 0.323
PE 277 (25.7) 32 (22.4) 309 (25.3)
DVT+PE 66 (6.1) 13 (9.1) 79 (6.5)
Thrombophilia
Yes 390 (36.9) 68 (49.6) 458 (38.3) 0.005
No 668 (63.1) 69 (50.4) 737 (61.7)
Family history
Yes 269 (23.5) 47 (32.4) 316 (24.5) 0.024
No 875 (76.5) 98 (67.6) 973 (75.5)

DNA was not enough for genotyping in 11 samples for FTO rs9939609 polymorphism, DVT, deep vein thrombosis; PE, pulmonary embolism; BMI, body mass index. P-value, Chi square test until unless indicated,

*

Student T-test,

Mann-Whitney U test.

comparing non-recurrent with recurrent VTE. IQR, Interquartile range. Thrombophilia, presence of factor V Leiden, factor II G20210A, or antithrombin, protein C or free protein S levels below the laboratory reference ranges.